Since 1986, MAPS has worked tirelessly to build and share the blueprint for ending psychedelic prohibition. This MAPS blueprint is being used throughout the world to take an evidence-based approach to psychedelic healing. As a nonprofit, MAPS has relied on the support of people like you to pursue our mission, build a…
Visit maps.org → RSS feedOn Hacker News Aug 2017 – Mar 2022
Society, Policy & Culture 5Tech Industry & Business 3Science & Space 2
The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of posttraumatic stress disorder (PTSD). MAPS and the FDA have also reached agreement under the Special…
Today, California State Senator Scott Wiener (D-San Francisco) introduced Senate Bill 519 to decriminalize certain psychedelics in the interest of public health and safety and to address some harms of the War on Drugs. The bill would decriminalize MDMA, LSD, DMT, psilocybin, psilocyn, ibogaine, and mescaline and…
Fifty years after the War on Drugs was officially declared and psychedelic substance prohibition began in contravention of evidence supporting therapeutic use, the California State Senate has taken the first Legislative step to dismantle psychedelic prohibition with a 21-16 vote on June 1, 2021, in favor of Senate…
CONTACT: Brad Burge, Director of Strategic Communications, MAPS Media Requests: Press Resouces:
Our Expanded Access Program study site at Sage Integrative Health in Berkeley, California, began screening participants for MDMA-assisted therapy for PTSD in early March. Our multi-site expanded access study site for MDMA-assisted therapy for patients with treatment-resistant PTSD at the Pearl Psychedelic Institute in…